Department of Otolaryngology-Head and Neck Surgery, Cancer Center Amsterdam, Amsterdam UMC, VU University medical center, De Boelelaan, 1117, Amsterdam, The Netherlands.
Curr Oncol Rep. 2020 Jun 29;22(8):81. doi: 10.1007/s11912-020-00938-3.
To understand why some patients respond to immunotherapy but many do not, a clear picture of the tumor microenvironment (TME) of head and neck squamous cell carcinoma (HNSCC) is key. Here we review the current understanding on the immune composition per HNSCC subsite, the importance of the tumor's etiology and the prognostic power of specific immune cells.
Large cohort data are mostly based on deconvolution of transcriptional databases. Studies focusing on infiltrate localization often entail small cohorts, a mixture of HNSCC subsites, or focus on a single immune marker rather than the interaction between cells within the TME. Conclusions on the prognostic impact of specific immune cells in HNSCC are hampered by the use of heterogeneous or small cohorts. To move forward, the field should focus on deciphering the immune composition per HNSCC subsite, in powered cohorts and considering the molecular diversity in this disease.
为了了解为什么有些患者对免疫疗法有反应,而许多患者却没有,对头颈部鳞状细胞癌(HNSCC)的肿瘤微环境(TME)有一个清晰的认识是关键。在这里,我们回顾了目前对每个 HNSCC 亚部位的免疫组成、肿瘤病因的重要性以及特定免疫细胞的预后能力的理解。
大量队列数据主要基于转录数据库的去卷积。侧重于浸润定位的研究通常涉及小队列、HNSCC 亚部位的混合,或者侧重于单个免疫标志物,而不是 TME 内细胞之间的相互作用。由于使用了异质或小队列,HNSCC 中特定免疫细胞的预后影响的结论受到阻碍。为了取得进展,该领域应专注于在功能强大的队列中解析每个 HNSCC 亚部位的免疫组成,并考虑该疾病中的分子多样性。